Format

Send to

Choose Destination
Pediatr Nephrol. 2014 Mar;29(3):329-32. doi: 10.1007/s00467-013-2722-2. Epub 2013 Dec 22.

Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?

Author information

1
Mount Sinai Medical School, 1 Gustave L. Levy Pl, New York, NY, 10029, USA, jeff.saland@mssm.edu.

Abstract

Patients with end-stage renal disease (ESRD) due to atypical HUS (aHUS) now have several potential options that can enable successful kidney transplantation. This editorial addresses these options by considering key factors that are important when making an individual treatment decision.

PMID:
24362724
DOI:
10.1007/s00467-013-2722-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center